Sclerosing Peritonitis and Propranolol
- 1 September 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 138 (9) , 1424-1426
- https://doi.org/10.1001/archinte.1978.03630340090032
Abstract
Sclerosing peritonitis developed in a 43-year-old man with angina pectoris who had been receiving the beta-adrenergic receptor antagonist, propranolol. The patient had abdominal and back pain, weight loss, a midabdominal fullness, ascites, and evidence of partial small bowel obstruction. At surgery, the small bowel was distended and encased by dense fibrous tissue. Infectious and neoplastic causes of fibrosing peritoneal inflammation were excluded. The patient described in this report illustrates several features commonly experienced by individuals who developed sclerosing peritonitis associated with betaadrenergic receptor blockade therapy. To my knowledge, the development of ascites and considerable ascitic fluid leukocytosis have not been described previously with this disorder. (Arch Intern Med 138:1424-1426, 1978)This publication has 5 references indexed in Scilit:
- FREQUENCY OF EYE COMPLAINTS AND RASHES AMONG PATIENTS RECEIVING PRACTOLOL AND PROPRANOLOLThe Lancet, 1977
- Sclerosing peritonitis due to practolol.BMJ, 1977
- Cutaneous and Ocular Reactions to PractololBMJ, 1974
- The pathology of idiopathic retroperitoneal fibrosisJournal of Clinical Pathology, 1970
- Retractile MesenteritisNew England Journal of Medicine, 1962